BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 16996389)

  • 41. Utilization of substance abuse treatment services under Medicare, 2001-2002.
    Vandivort R; Teich JL; Cowell AJ; Chen H
    J Subst Abuse Treat; 2009 Jun; 36(4):414-9. PubMed ID: 18835680
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Domains and perceived benefits of treatment among patients with and without co-occurring disorders in inpatient substance use treatment.
    Bergly TH; Gråwe RW; Hagen R
    J Dual Diagn; 2014; 10(2):91-7. PubMed ID: 25392251
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The clinical management of co-morbidity.
    Pols RG
    Alcohol Alcohol Suppl; 1994; 2():485-90. PubMed ID: 8974372
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Blending addiction research and practice: strategies for technology transfer.
    Condon TP; Miner LL; Balmer CW; Pintello D
    J Subst Abuse Treat; 2008 Sep; 35(2):156-60. PubMed ID: 18337054
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comorbidity of migraine and psychiatric disorders--a national population-based study.
    Jette N; Patten S; Williams J; Becker W; Wiebe S
    Headache; 2008 Apr; 48(4):501-16. PubMed ID: 18070059
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cost-effectiveness analysis of integrated care for people with HIV, chronic mental illness and substance abuse disorders.
    Weaver MR; Conover CJ; Proescholdbell RJ; Arno PS; Ang A; Uldall KK; Ettner SL
    J Ment Health Policy Econ; 2009 Mar; 12(1):33-46. PubMed ID: 19346565
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dual diagnosis in Spain.
    Gual A
    Drug Alcohol Rev; 2007 Jan; 26(1):65-71. PubMed ID: 17364838
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Profile of young people attending alcohol and other drug treatment services in Aotearoa, New Zealand: clinical file search.
    Schroder R; Sellman D; Frampton C; Deering D
    Aust N Z J Psychiatry; 2008 Nov; 42(11):963-8. PubMed ID: 18941961
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Relationship of sex to symptom severity, psychiatric comorbidity, and health care utilization in 163 subjects with borderline personality disorder.
    McCormick B; Blum N; Hansel R; Franklin JA; St John D; Pfohl B; Allen J; Black DW
    Compr Psychiatry; 2007; 48(5):406-12. PubMed ID: 17707247
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The epidemiology of psychiatric disorders among repeat DUI offenders accepting a treatment-sentencing option.
    Shaffer HJ; Nelson SE; LaPlante DA; LaBrie RA; Albanese M; Caro G
    J Consult Clin Psychol; 2007 Oct; 75(5):795-804. PubMed ID: 17907861
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The association of persistent pain with out-patient addiction treatment outcomes and service utilization.
    Caldeiro RM; Malte CA; Calsyn DA; Baer JS; Nichol P; Kivlahan DR; Saxon AJ
    Addiction; 2008 Dec; 103(12):1996-2005. PubMed ID: 18855809
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Substance use disorder among older adults in the United States in 2020.
    Han B; Gfroerer JC; Colliver JD; Penne MA
    Addiction; 2009 Jan; 104(1):88-96. PubMed ID: 19133892
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Gender differences in axis I and axis II comorbidity in patients with borderline personality disorder.
    Tadić A; Wagner S; Hoch J; Başkaya O; von Cube R; Skaletz C; Lieb K; Dahmen N
    Psychopathology; 2009; 42(4):257-63. PubMed ID: 19521142
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Substance use behaviors, mental health problems, and use of mental health services in a probability sample of college students.
    Cranford JA; Eisenberg D; Serras AM
    Addict Behav; 2009 Feb; 34(2):134-45. PubMed ID: 18851897
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Detection methods of the drug-addiction and alcoholism treatment programme of the Spanish National Railway Company (RENFE).
    Cabrero E; Gómez-Acebo A; García-Alcázar I; Luna JD; Luna A
    Med Lav; 2003; 94(4):364-73. PubMed ID: 14526495
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Changing the world: the design and implementation of comprehensive continuous integrated systems of care for individuals with co-occurring disorders.
    Minkoff K; Cline CA
    Psychiatr Clin North Am; 2004 Dec; 27(4):727-43. PubMed ID: 15550290
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Barriers to methamphetamine withdrawal treatment in Australia: findings from a survey of AOD service providers.
    Pennay AE; Lee NK
    Drug Alcohol Rev; 2009 Nov; 28(6):636-40. PubMed ID: 19930017
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Adolescents with co-occurring mental health and substance use disorders in primary care.
    Gee RL; Espiritu RC; Huang LN
    Adolesc Med Clin; 2006 Jun; 17(2):427-52. PubMed ID: 16814701
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Use of mental health care and substance abuse treatment among adults with co-occurring disorders.
    Harris KM; Edlund MJ
    Psychiatr Serv; 2005 Aug; 56(8):954-9. PubMed ID: 16088012
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Unmet needs for comprehensive services in outpatient addiction treatment.
    Pringle JL; Emptage NP; Hubbard RL
    J Subst Abuse Treat; 2006 Apr; 30(3):183-9. PubMed ID: 16616161
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.